12:00 AM
 | 
Mar 18, 2013
 |  BC Week In Review  |  Company News  |  Other News

GlaxoSmithKline pharmaceuticals news

GlaxoSmithKline said it will close its Sirtris Pharmaceuticals Inc. facility in Cambridge, Mass., and integrate the Discovery Performance Unit (DPU), which has been studying...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >